Top Markets
Coin of the day
Fuse Medical, Inc. Fuse Medical, Inc.

Fuse Medical, Inc.

FZMD
Rang in aandelen #37740
Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based... Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based manufacturer and supplier of medical device implants. Its product portfolio primarily encompasses a wide range of orthopedic implants. This includes specialized internal and external fixation devices for the foot and ankle, as well as plating systems and total joint reconstruction implants designed for upper and lower extremities. Additionally, Fuse Medical provides solutions for soft tissue fixation and augmentation, catering to sports medicine procedures. The company's offerings extend to comprehensive spinal implants, addressing indications such as trauma, degenerative disc disease, and various deformities. Beyond its orthopedic line, the company also supplies osteo-biologics and regenerative products. These encompass a variety of materials such as human allografts, tendons, synthetic skin, bone substitutes, and other regenerative tissues. Fuse Medical's client base includes hospitals, diverse medical facilities, and a network of sub-distributors.
Aandeelprijs
$0.02
Laatst gesynchroniseerd: 2026-08-13
Marktkapitalisatie
$1.48M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-71.43%
Land
US
Handel Fuse Medical, Inc. (FZMD)

Categorie

Winst voor Fuse Medical, Inc. (FZMD)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Fuse Medical, Inc. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Fuse Medical, Inc. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
$1.42B -
US